This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 4 EPO patents. Top assignees: Dritte Patentportfolio Beteiligungsgesellschaft Mbh &Co. Kg, Leibniz-Institut Fuer Naturstoff-Forschung Und Infektionsbiologie, Leibniz-Institut Fuer Naturstoff-Forschung Und Infektionsbiologie E.v. Hans-Knoell-Institute (Hki). Active years: 2007-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Weimar, DE (2007)
- Jena, DE (2014 - 2016)
Company Filing History:
1 out of 13 
1 out of 1 
1 out of 1 Years Active: 2007-2016
Title: The Innovative Contributions of Hans-Martin Dahse
Introduction
Hans-Martin Dahse is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel compounds for medical applications. With a total of five patents to his name, Dahse's work has the potential to impact the treatment of various diseases.
Latest Patents
Among his latest patents, Dahse has developed Chartreusin analogues, which are novel compounds aimed at treating cancer and other diseases. This invention focuses on pharmaceutical compositions that utilize these analogues for therapeutic purposes. Additionally, he has worked on Benzopyranobenzothiazinones, which are biologically active compounds with applications as fungicides, antibiotics, and antitumor agents. This invention includes methods for producing phaeofungins and their use in various medical applications.
Career Highlights
Dahse has been associated with prominent research institutions, including the Leibniz Institute for Natural Product Research and Infection Biology. His work at this institute has allowed him to explore innovative solutions in the field of natural products and their applications in medicine. He has also been involved with Dritte Patentportfolio Beteiligungsgesellschaft mbH & Co. KG, where he has contributed to the management and commercialization of patents.
Collaborations
Throughout his career, Dahse has collaborated with esteemed colleagues such as Christian Hertweck and Kirstin Scherlach. These collaborations have fostered a productive environment for research and innovation, leading to advancements in the pharmaceutical field.
Conclusion
Hans-Martin Dahse's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for new treatments and solutions in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile